May 23: Japanese drugmaker Daiichi Sankyo has quietly stood by its decision to purchase Ranbaxy in 2008. Now, the company is publicly suggesting it was defrauded in the $4.6 billion acquisition. More
Culture changes at banks come and go, but many fail. How Barclays plans to pull this off.
Federal law entitles you to unpaid time off for family health issues (or your own), but how do you answer coworkers who resent it?
These employers are boosting retention by sending workers across the globe, where they help communities in remote parts of Nepal, Africa, and Brazil.
At a time when their very survival seems up in the air, how can firms spot and hire the few candidates that will thrive in Big Law?
The conventional wisdom is that market forces don't apply to pricing for medical care. A new study of the cosmetic surgery industry shows how wrong that belief is.
From a pet relocation service, a wine lifestyle marketer, to a scrap metal regenerator, America's urban core is home to a variety of fast-growing companies.
While short-term shareholders may cheer the JP Morgan CEO's retention of the chair spot, this will harm the board's ability to rein in risk.
Move over Gerber, entrepreneur Shazi Visram is hungry for market share.
The highly anticipated JPMorgan shareholder meeting felt more like a lunch gathering of a local Toastmasters than Ground Zero of the governance movement.
Towns are taking a page from the corporate world in an effort to make strapped municipal governments more efficient.
Monarchs can deliver competitive advantages to businesses operating in their respective realms. More
|McDonald's gives Charles Ramsey free food for a year|
|Japan stocks rebound after big plunge|
|Mailbox comes to the iPad|
|Bitcoin more powerful than fastest supercomputers|
|Stocks claw back from steep losses|